| First Author | Moreno-Garcia MA | Year | 2014 |
| Journal | Mol Genet Metab | Volume | 112 |
| Issue | 3 | Pages | 198-204 |
| PubMed ID | 24889031 | Mgi Jnum | J:212387 |
| Mgi Id | MGI:5581344 | Doi | 10.1016/j.ymgme.2014.05.002 |
| Citation | Moreno-Garcia MA, et al. (2014) The Mmachc gene is required for pre-implantation embryogenesis in the mouse. Mol Genet Metab 112(3):198-204 |
| abstractText | Patients with mutations in MMACHC have the autosomal recessive disease of cobalamin metabolism known as cblC. These patients are unable to convert cobalamin into the two active forms, methylcobalamin and adenosylcobalamin and consequently have elevated homocysteine and methylmalonic acid in blood and urine. In addition, some cblC patients have structural abnormalities, including congenital heart defects. MMACHC is conserved in the mouse and shows tissue and stage-specific expression pattern in midgestation stage embryos. To create a mouse model of cblC we generated a line of mice with a gene-trap insertion in intron 1 of the Mmachc gene, (Mmachc(Gt(AZ0348)Wtsi)). Heterozygous mice show a 50% reduction of MMACHC protein, and have significantly higher levels of homocysteine and methylmalonic acid in their blood. The Mmachc(Gt) allele was inherited with a transmission ratio distortion in matings with heterozygous animals. Furthermore, homozygous Mmachc(Gt) embryos were not found after embryonic day 3.5 and these embryos were unable to generate giant cells in outgrowth assays. Our findings confirm that cblC is modeled in mice with reduced levels of Mmachc and suggest an early requirement for Mmachc in mouse development. |
